This Is MS Multiple Sclerosis Community: Knowledge & Support

I don't know if you can ... but reach out to Rose2 ... she had an azygous stent (and to quote her) "best thing ever" ... you can read her testimony in threads throughout the CCSVI forum, as well as in the tracking thread stickied at the top of the page.

That is exactly what happen to me after Poland. Now I have an IR in the states - 7hrs drive is "local" for me and necessary since I had more than one complication...

Be prepared, it is not a one shot deal. You should also have your GP on board to follow you blood thinner regimen if required.

Good luck!
S

In response to this thread, I wanted you to know that this is a presentation we will be making at the SIR meeting in March.

TITLE: Safety of outpatient endovascular treatment of the internal jugular and azygos veins for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis: a retrospective analysis

AUTHORS: Mandato, Kenneth; Hegener, Paul; Siskin, Gary; Englander, Meridith; Garla, Sreeivas; Herr, Allen
Albany Medical Center, Albany, NY, United States.

Purpose: To evaluate the safety of outpatient endovascular treatment of the internal jugular and azygos veins in MS patients with CCSVI.

Materials and Methods: A retrospective analysis of MS patients with CCSVI undergoing endovascular treatment of the internal jugular and/or azygos veins was performed to identify and describe the adverse events occurring within 30 days.

Results: Over 7 months, 247 procedures were performed in 231 patients. The mean patient age was 48.2 years (range: 25.7-70.2 years); 63.7% were female and 36.3% were male. 49.0% (121/247) of the procedures were performed in a hospital and 51.0% (126/247) were performed in the office setting. 92.7% (229/247) were primary procedures while 7.3% (18/247) were secondary due to restenosis. For patients treated primarily, 86.5% (198/229) underwent angioplasty and 11.4% (26/229) underwent stent placement of at least one vessel; the remaining 5 patients were not treated. Of the 18 patients treated due to restenosis, 50% underwent angioplasty and 50% underwent stent placement. After 99.2% (245/247) of the procedures, patients were discharged within 3 hours. A post-procedure, transient headache was reported in 8.5% (21/247); this persisted beyond 30 days in 1 patient. Neck pain was reported in 15.8% of patients (39/247); 53.8% (21/39) of these patients underwent stent placement. 1.7% (4/231) of patients were retreated within 30 days due to symptomatic restenosis. Sustained cardiac arrhythmias were observed in 3 patients during the procedure with 2/3 patients requiring hospital admission. One of these patients, who underwent a complex procedure for in-stent thrombosis, required a prolonged hospitalization due to a stress-induced cardiomyopathy.

Conclusion: Endovascular treatment of CCSVI in MS patients is a safe procedure when performed on an outpatient basis. Cardiac monitoring is essential to permit detection and rapid treatment of patients with procedure-induced arrhythmias. Post-procedure ultrasound is recommended to detect venous thrombosis. In addition, consideration should be given to performing complex re-interventions in a hospital given the complication risk in this sub-population of patients.

1st: Bravo Dr Siskin and your team!
Wow! incredible everything that happen in one year!

Q: In all of those treated anybody (%) worse than pre-procedure?
I know I am even after stent stenosis, jug collapse and thrombosis corrected - I was not treated by you.

Has your 1/3,1/3,1/3 results changed since your July presentation in NY?

Thank you
S

Thanks so much for sharing, Dr Siskin! Great info/stats here. Keep on keeping us informed!

Amazing....many thank's for all you have done and continue to do!!! I just knew it! Lee say's Thank you Dr. Siskin! See you soon!

_________________
GOD BLESS.... CCSVI treatment Dr. Siskin great doc....symptom's improved for about 3 week's (gait, balance, spasticity) now back to square 1...